68 related articles for article (PubMed ID: 2477856)
1. Intravenous infusion of iloprost and prostaglandin E1 (PGE1): cardiovascular profile in anaesthetized rabbits.
Müller B; Maass B; Stürzebecher S
Prog Clin Biol Res; 1989; 301():401-5. PubMed ID: 2477856
[No Abstract] [Full Text] [Related]
2. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of iloprost and alprostadil on platelets, blood pressure and fibrinolysis.
Witt W; Baldus B
Prog Clin Biol Res; 1989; 301():347-51. PubMed ID: 2477854
[No Abstract] [Full Text] [Related]
5. [Are there pulmonary vascular or respiratory effects of prostaglandin vehicles (ethanol, glycine buffer) after intravenous infusion or inhalation?].
Bund M; Winterhalter M; Weilbach C; Piepenbrock S
Pneumologie; 2007 Nov; 61(11):721-4. PubMed ID: 17729206
[TBL] [Abstract][Full Text] [Related]
6. Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo.
Kisch-Wedel H; Kemming G; Meisner F; Flondor M; Bruhn S; Koehler C; Messmer K; Zwissler B
Eur J Pharmacol; 2005 Jul; 517(3):208-16. PubMed ID: 15993879
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular effects of the slow intravenous infusion of verapamil].
de Moura RS
Arq Bras Cardiol; 1982 Feb; 38(2):111-4. PubMed ID: 7159243
[No Abstract] [Full Text] [Related]
8. Effects of prostaglandin E1 (PGE1) in pulmonary hypertension due to chronic obstructive pulmonary disease (COPD).
Meissner E; Creutzig A; Fabel H
Prog Clin Biol Res; 1989; 301():253-7. PubMed ID: 2798450
[No Abstract] [Full Text] [Related]
9. Effect of intravenous iloprost and alprostadil (PGE1) on peripheral resistance during femoro-distal reconstructions.
Krueger U; Scholz H; Heise M; Adeberg P; Petzold M; Zanow J; Karrenberg R
Int Angiol; 2000 Dec; 19(4):358-65. PubMed ID: 11305737
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
Pan S; Xiao M; Liu Y
Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits.
Inoue K; Aoki Y; Hayashi M; Kitahara S; Tanabe H; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):980-4. PubMed ID: 7488317
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular effects of iloprost: experimental study].
Marzilli M; Levantesi D; Dalle Vacche M; Trivella MG; Pelosi G; Taddei L
Cardiologia; 1987 Sep; 32(9):1015-8. PubMed ID: 2446762
[No Abstract] [Full Text] [Related]
13. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
[TBL] [Abstract][Full Text] [Related]
14. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
Heidrich H
Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
[TBL] [Abstract][Full Text] [Related]
15. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep.
Ogletree ML; Brigham KL
Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effectiveness of prostaglandins (PGs) in peripheral vascular disease (PVD).
Linet OI; Mohberg NR
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():307-10. PubMed ID: 2473609
[No Abstract] [Full Text] [Related]
18. Significance of the cardioprotective effect of prostanoids and indomethacin.
Mentz P; Pawelski KE; Giessler C; Mest HJ; Schwab M; Kersten T; Czeslick E
Biomed Biochim Acta; 1988; 47(10-11):S48-51. PubMed ID: 2470359
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects.
Lehmann HD; Giertz H; Kretzschmar R; Lenke D; von Philipsborn G; Raschack M; Schuster J
Arzneimittelforschung; 1981; 31(9a):1544-57. PubMed ID: 7197969
[No Abstract] [Full Text] [Related]
20. Prostaglandin E1 induces intraosseous hypotension under conditions of normal arterial pressure.
Kakiuchi M
Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):75-8. PubMed ID: 15207521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
